Hospitalist Doctors in District Of Columbia Medicare Details, Address, Contact
63 Hospitalist doctors found. Showing 61 - 63
 Erin Duquette-quandt, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 3800 Reservoir Rd Nw, Department Of Medicine, Washington, DC 20007 Phone: 202-444-8168 Fax: 877-303-1460 |
Millicent Yee, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 3800 Reservoir Rd Nw, Dept Of Medicine, Washington, DC 20007 Phone: 202-443-8168 Fax: 877-303-1460 |
Dr. Freba Zainab Farhat, M.D. Hospitalist Medicare: Medicare Enrolled Practice Location: 110 Irving St Nw, Washington, DC 20010 Phone: 301-951-2400 Fax: 301-951-2401 |
News Archive
Biomarker analysis of Vectibix for mCRC published in New England Journal of Medicine
Amgen today announced the publication of a biomarker analysis of Vectibix (panitumumab) in combination with FOLFOX, a type of oxaliplatin-based chemotherapy, for the first-line treatment of patients with metastatic colorectal cancer.
Progress on MDG targets is 'key priority' in 2010 for U.N. Secretary-General
U.N. Secretary-General Ban Ki-moon on Monday called 2010 "the year of development" and said "he would make the drive to achieve" the Millennium Development Goals (MDGs) by 2015 "one of his key priorities this year," Agence France-Presse/My Sinchew reports.
A renewed effort to reduce global toll of maternal and child deaths
Widespread global use of known and proven maternal and childcare techniques, practices, and therapies could save the lives of millions of women, newborns and children each year, according to a new analysis prepared for a mid-April meeting of world leaders and technical experts on maternal and child health.
Danaher to acquire mass spectrometry business from Life Technologies Corporation
Life Technologies Corporation (NASDAQ:LIFE) today announced it has signed a definitive agreement to sell its ownership stake in its mass spectrometry business, operated as a joint venture, to Danaher Corporation (NYSE:DHR) for $450 million in cash. Danaher has also signed an agreement to acquire Life Technologies' joint venture partner in the mass spectrometry business, MDS Analytical Technologies, a division of MDS Inc. (NYSE:MDZ). The transaction is expected to close in the fourth quarter of 2009.
Ruboxistaurin may reduce vision loss from diabetes-induced eye disease
Eli Lilly and Company's investigational compound ruboxistaurin may reduce vision loss from diabetes-induced eye disease, according to new analyses of previously reported data presented at the 2004 Joint Meeting of the American Academy of Ophthalmology and the European Society of Ophthalmology in New Orleans, La.
› Verified 5 days ago